Practice variation and missed opportunities for reperfusion in ST-segment-elevation myocardial infarction: findings from the Global Registry of Acute Coronary Events (GRACE)
- 1 February 2002
- journal article
- Published by Elsevier BV in The Lancet
- Vol. 359 (9304), 373-377
- https://doi.org/10.1016/s0140-6736(02)07595-5
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Temporal trends in the treatment of over 1.5 million patients with myocardial infarction in the U.S. from 1990 through 1999Journal of the American College of Cardiology, 2000
- Long-term benefit of primary angioplasty compared to thrombolytic therapy for acute myocardial infarctionPublished by Oxford University Press (OUP) ,2000
- ACC/AHA guidelines for the management of patients with unstable angina and non–st-segment elevation myocardial infarctionJournal of the American College of Cardiology, 2000
- Geographic variability in outcomes within an international trial of glycoprotein IIb/IIIa inhibition in patients with acute coronary syndromes. Results from PURSUITEuropean Heart Journal, 2000
- Treatment and outcome of myocardial infarction in hospitals with and without invasive capabilityJournal of the American College of Cardiology, 2000
- 1999 update: ACC/AHA guidelines for the management of patients with acute myocardial infarctionJournal of the American College of Cardiology, 1999
- Early Revascularization in Acute Myocardial Infarction Complicated by Cardiogenic ShockNew England Journal of Medicine, 1999
- Contribution of trends in survival and coronar y-event rates to changes in coronary heart disease mortality: 10-year results from 37 WHO MONICA Project populationsThe Lancet, 1999
- Can We Provide Reperfusion Therapy to All Unselected Patients Admitted With Acute Myocardial Infarction?Journal of the American College of Cardiology, 1997
- Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patientsThe Lancet, 1994